Man with magnifier on dark background

I Can’t Invest in Google, Apple, or Nvidia

Have you ever seen a revenue chart from Netflix? It’s gorgeous!

Or how about Google? My heart skips a beat!

Or Apple? OK, not as pretty but still…

These companies have a long history of growing revenue, year after year. Even during the worst economic times in the past 20 years. So why don’t I go out and buy Apple, Google, and Netflix as part of my new public portfolio?

Because I already own lots of them.

48% of my portfolio is invested in US stocks broadly, such as index funds.

My best “back of the envelope” estimate is that 1.21% of my current portfolio is Google (Alphabet), 1.89% of it is Apple, and 2.3% of it is Nvidia. So investing small amounts into those companies is pointless.

I can’t even count that a company like Berkshire Hathaway (which is part of the S&P 500) has 20% of its funds invested in Apple!

My goal with the Divchallenge Portfolio is to find companies I am underweight in, and my investment might be worthwhile.

For instance, one reason I’m including crypto in this bucket is that I probably don’t have enough exposure to it.

Unfortunately, I will have to deliberately exclude the following companies from this new portfolio, despite my strong liking for them.

  • Nvidia (NVDA)
  • Microsoft (MSFT)
  • Apple (AAPL)
  • Amazon (AMZN)
  • Alphabet (GOOGL/GOOG)
  • Meta Platforms (META
  • Broadcom (AVGO)
  • Berkshire Hathaway (BRK B)
  • Tesla (TSLA)
  • JPMorgan Chase (JPM)

Similar Posts

  • Evaluating Eli Lilly

    I am still deciding what my first investment should be. A friend suggested Eli Lilly, so let’s see how it is. Criteria #1: I like to see consistent revenue growth over time. To start, let’s look at how its revenue and earnings have grown over time. Eli Lilly appears to grow its revenue consistently over…

  • Evaluating Novo Nordisk

    Criteria #1: I like to see consistent revenue growth over time. To start, let’s look at how its revenue and earnings have grown over time. Novo Nordisk appears to grow its revenue consistently over time. Of course, it’s hit a home run with its weight loss drug, Ozempic. As I mentioned in the Eli Lilly…

  • Regret?

    The two main stocks that I own in the Public Portfolio have not done well so far. (I also own a Total Stock Market ETF.) Coursera is down about 11% from where I bought it. I guess they’re not benefiting from the relationship with OpenAI ChatGPT that I thought they would. And Novo Nordisk is…

  • Introducing Coursera

    I watched a recent OpenAI announcement with interest. OpenAI is now offering direct access to select applications within ChatGPT. According to OpenAI’s presentation, approximately 800 million people use ChatGPT every week. Companies that are promoted (even rarely) within ChatGPT have a significant source of free traffic and/or new user sign-ups. If a user asks ChatGPT…